Analysts Set Azenta, Inc. (NASDAQ:AZTA) PT at $69.60

Shares of Azenta, Inc. (NASDAQ:AZTA) have been given a consensus recommendation of “Hold” by the six analysts that are presently covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $69.60.

Several research analysts have recently weighed in on AZTA shares. Jefferies Financial Group started coverage on Azenta in a research report on Thursday, April 4th. They issued a “hold” rating and a $64.00 price objective for the company. Stephens reaffirmed an “equal weight” rating and issued a $70.00 target price on shares of Azenta in a research report on Thursday, February 8th. Evercore ISI decreased their target price on Azenta from $64.00 to $60.00 and set an “in-line” rating for the company in a research report on Thursday, April 4th. Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 target price on shares of Azenta in a research report on Monday, April 8th. Finally, B. Riley boosted their target price on Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research report on Thursday, February 1st.

Institutional Investors Weigh In On Azenta

A number of hedge funds have recently modified their holdings of AZTA. FMR LLC bought a new stake in shares of Azenta in the 2nd quarter worth approximately $172,000. Credit Suisse AG bought a new stake in Azenta during the 2nd quarter valued at $4,451,000. LPL Financial LLC bought a new stake in Azenta during the 2nd quarter valued at $3,697,000. Millennium Management LLC bought a new stake in Azenta during the 2nd quarter valued at $6,091,000. Finally, Cubist Systematic Strategies LLC bought a new stake in Azenta during the 2nd quarter valued at $736,000. Institutional investors own 99.08% of the company’s stock.

Azenta Trading Down 2.6 %

Shares of NASDAQ AZTA opened at $52.18 on Friday. The firm has a market cap of $2.91 billion, a P/E ratio of -168.32 and a beta of 1.53. Azenta has a 1-year low of $36.01 and a 1-year high of $69.16. The business’s 50 day moving average is $61.52 and its 200-day moving average is $59.02.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Wednesday, February 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The business had revenue of $154.32 million for the quarter, compared to the consensus estimate of $151.86 million. Azenta had a positive return on equity of 0.49% and a negative net margin of 2.92%. Analysts forecast that Azenta will post 0.27 EPS for the current year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.